
Virapt 3% Eye Ointment
Marketer
Chethana Pharmaceuticals
Salt Composition
Acyclovir (3% w/w)
Overview Virapt 3% Eye Ointment
Herpes simplex virus-related eye infections are treated with the antiviral medication, Virapt 3% ophthalmic ointment. This ointment inhibits viral replication on the corneal surface, thus halting further virus production and resolving the infection. Virapt 3% is for topical application only. Adhere strictly to your physician's prescribed dosage and duration. Always wash hands before and after application. Continue treatment as directed, even after symptom improvement. A brief stinging sensation and redness may occur immediately after application; these are generally transient and self-limiting. Report any persistent side effects to your doctor. Refrain from wearing contact lenses during treatment.
Uses of Virapt 3% Eye Ointment
Herpes simplex virus-induced ocular infections: management strategies
Major Benefits of Virapt 3% Eye Ointment:
Apply this medication externally only. Administer the prescribed dosage and frequency as directed by your physician. Always consult the product label for application instructions prior to use. Keep the applicator tip near, but not touching, the eye. Gently compress the container to dispense the medication into the lower conjunctival sac.
Common Side effects of Virapt 3% Eye Ointment:
- Stinging sensation
- Eye redness
How to use Virapt 3% Eye Ointment:
Apply this medication externally only. Follow your physician's instructions precisely regarding dosage and treatment length. Always consult the product label for application details prior to use. Keep the applicator near, but not touching, the eye. Apply a small amount of the medicine to the lower eyelid by gently pressing the tube.
How Virapt 3% Eye Ointment works:
Herpes simplex virus-related eye infections are treated with Virapt 3% ophthalmic ointment, an antiviral agent. Its mechanism of action involves inhibiting viral replication on the corneal surface, thereby halting further infection spread and promoting healing.
SAFETY ADVICE
AlcoholNone
No known drug interactions.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Virapt 3% ophthalmic ointment in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
The use of Virapt 3% Eye Ointment while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Application of Virapt 3% ophthalmic ointment typically does not impair driving ability.
KidneyNone
No known drug interactions.
LiverNone
No known drug interactions.
What if you forget to take Virapt 3% Eye Ointment :
Should you forget a dose of Virapt 3% Eye Ointment, apply it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed application and resume your usual dosing regimen. Avoid applying a double dose.
Facts to Know About Virapt 3% Eye Ointment
| Label | Value |
|---|---|
| Chemical Type | Base analog nucleotide |
| Developing Habits | No. |
| Treatment Category | Ophthalmology |
